Antiobesity Efficacy of a Novel Cannabinoid-1 Receptor Inverse Agonist, N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in Rodents

@article{Fong2007AntiobesityEO,
  title={Antiobesity Efficacy of a Novel Cannabinoid-1 Receptor Inverse Agonist, N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-\{[5-(trifluoromethyl)pyridin-2-yl]oxy\}propanamide (MK-0364), in Rodents},
  author={T. Fong and Xiao-ming Guan and D. Marsh and Chun-Pyn Shen and D. Stribling and Kim Rosko and Julie Lao and H. Yu and Y. Feng and J. Xiao and Lex H T van der Ploeg and M. Goulet and Williams K. Hagmann and Linus S. Lin and T. Lanza and James P. Jewell and P. Liu and S. Shah and Hongbo Qi and X. Tong and J. Wang and S. Xu and B. Francis and A. Strack and D. Macintyre and L. Shearman},
  journal={Journal of Pharmacology and Experimental Therapeutics},
  year={2007},
  volume={321},
  pages={1013 - 1022}
}
  • T. Fong, Xiao-ming Guan, +23 authors L. Shearman
  • Published 2007
  • Chemistry, Medicine
  • Journal of Pharmacology and Experimental Therapeutics
  • The cannabinoid-1 receptor (CB1R) has been implicated in the control of energy balance. To explore the pharmacological utility of CB1R inhibition for the treatment of obesity, we evaluated the efficacy of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364) and determined the relationship between efficacy and brain CB1R occupancy in rodents. MK-0364 was shown to be a highly potent CB1R inverse agonist that… CONTINUE READING
    95 Citations
    Metabolism and excretion of [14C]taranabant, a cannabinoid-1 inverse agonist, in humans
    • B. Karanam, C. Addy, +14 authors S. Kumar
    • Chemistry, Medicine
    • Xenobiotica; the fate of foreign compounds in biological systems
    • 2010
    • 1
    • Highly Influenced
    In vitro and in vivo metabolism of a novel cannabinoid-1 receptor inverse agonist, taranabant, in rats and monkeys
    • 5
    Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor.
    • 41
    Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity.
    • 34
    • PDF

    References

    SHOWING 1-10 OF 46 REFERENCES
    Synthesis, biological properties, and molecular modeling investigations of novel 3,4-diarylpyrazolines as potent and selective CB(1) cannabinoid receptor antagonists.
    • 147
    Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents.
    • 193
    Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding
    • 139
    Observational analysis of feeding induced by Δ9-THC and anandamide
    • 184
    Observational analysis of feeding induced by Delta9-THC and anandamide.
    • 103